It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
An international team of scientists, from Australia and the US, has developed an experimental direct-acting antiviral therapy that can reduce viral load by 99.9 per cent
When tested in SARS-Cov-2 infected mice the treatment with the therapy improved survival and loss of disease. Remarkably, in treated survivors, no virus could be detected in the lungs
"This treatment is designed to work on all betacoronaviruses such as the original SARS virus (SARS-CoV-1) as well as SARS-CoV-2 and any new variants that may arise in the future
"These nanoparticles are scalable and relatively cost-effective to produce in bulk,"
Source
originally posted by: trollz
An international team of scientists, from Australia and the US, has developed an experimental direct-acting antiviral therapy that can reduce viral load by 99.9 per cent
When tested in SARS-Cov-2 infected mice the treatment with the therapy improved survival and loss of disease. Remarkably, in treated survivors, no virus could be detected in the lungs
"This treatment is designed to work on all betacoronaviruses such as the original SARS virus (SARS-CoV-1) as well as SARS-CoV-2 and any new variants that may arise in the future
"These nanoparticles are scalable and relatively cost-effective to produce in bulk,"
Source
Scientists have developed an antiviral treatment that is 99.9% effective at getting rid of Covid-19. Mice treated with it showed no signs of the virus after treatment. This antiviral treatment is not only effective against Covid-19, but all potential future variants - and all betacoronaviruses in general. It's also cheap to mass-produce.
The Covid-19 "pandemic" is done.
"Treatment with virus-specific siRNA reduces viral load by 99.9 per cent. These stealth nanoparticles can be delivered to a wide range of lung cells and silence viral genes," said co-lead researcher Nigel McMillan, Professor at Menzies Health Institute Queensland (MHIQ) at Griffith.
The Covid-19 "pandemic" is done.
The new antiviral approach used gene-silencing RNA technology called siRNA (small-interfering RNA) to attack the virus' genome directly, which stops the virus from replicating
The new antiviral approach used gene-silencing RNA technology called siRNA (small-interfering RNA) to attack the virus' genome directly, which stops the virus from replicating, as well as lipid nanoparticles designed at Griffith University and City of Hope to deliver the siRNA to the lungs, the critical site of infection.
Small interfering RNA (siRNA), sometimes known as short interfering RNA or silencing RNA, is a class of double-stranded RNA non-coding RNA molecules, typically 20-27 base pairs in length, similar to miRNA, and operating within the RNA interference (RNAi) pathway. It interferes with the expression of specific genes with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation . . .
siRNAs can also be introduced into cells by transfection. Since in principle any gene can be knocked down by a synthetic siRNA with a complementary sequence, siRNAs are an important tool for validating gene function and drug targeting in the post-genomic era.
originally posted by: butcherguy
a reply to: MichiganSwampBuck
I did edit to my post above.
At least the virus genome is the target here.
mRNA 'vaccines' they made target human cells.